Equibles does not estimate personal net worth.
Get an email with a short summary when Bristol Myers Squibb Co publishes a filing, an earnings call transcript or a press release.
Get BMY alertsBristol Myers Squibb Co reported in an 8-K filed July 25, 2025 that Cristian Massacesi was appointed Executive Vice President, Chief Medical Officer, and Head of Development, effective August 1, 2025. The proxy statement of Bristol Myers Squibb Co reports total compensation of $10,072,950 for Cristian Massacesi in fiscal 2025, including a base salary of $388,462. Cristian Massacesi has spoken on 1 earnings call across 1 company, most recently for Bristol Myers Squibb Co on April 30, 2026. Bristol Myers Squibb Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Bristol Myers Squibb Co includes Christopher Boerner (CEO, COO and Board Member), Christopher Boerner, Ph.D. (CEO, COO and Board Member), David Elkins (CFO) and 6 others.
“Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development, effective August 1, 2025.”
“Let me start with the fact that we have a very data-rich 2026 and even probably more 2027. And let me start with what we already achieved. Because in him, I think we had a positive MRD with iberdomide in Excalibur in 25, and we are expecting the PFS later this year.”
Proxy statement
Start not stated–present
Last confirmed March 25, 2026
Drug Manufacturers - General · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bristol Myers Squibb Co (BMY) | M.D. EVP, Chief Medical Officer, Head of Development | $388,462 | $10,072,950 |
